Abstract

Background: Sepsis-induced coagulopathy (SIC) denotes an increased mortality rate and poorer prognosis in septic patients.Objectives: Our study aimed to develop and validate machine-learning models to dynamically predict the risk of SIC in critically ill patients with sepsis.Methods: Machine-learning models were developed and validated based on two public databases named Medical Information Mart for Intensive Care (MIMIC)-IV and the eICU Collaborative Research Database (eICU-CRD). Dynamic prediction of SIC involved an evaluation of the risk of SIC each day after the diagnosis of sepsis using 15 predictive models. The best model was selected based on its accuracy and area under the receiver operating characteristic curve (AUC), followed by fine-grained hyperparameter adjustment using the Bayesian Optimization Algorithm. A compact model was developed, based on 15 features selected according to their importance and clinical availability. These two models were compared with Logistic Regression and SIC scores in terms of SIC prediction.Results: Of 11,362 patients in MIMIC-IV included in the final cohort, a total of 6,744 (59%) patients developed SIC during sepsis. The model named Categorical Boosting (CatBoost) had the greatest AUC in our study (0.869; 95% CI: 0.850–0.886). Coagulation profile and renal function indicators were the most important features for predicting SIC. A compact model was developed with an AUC of 0.854 (95% CI: 0.832–0.872), while the AUCs of Logistic Regression and SIC scores were 0.746 (95% CI: 0.735–0.755) and 0.709 (95% CI: 0.687–0.733), respectively. A cohort of 35,252 septic patients in eICU-CRD was analyzed. The AUCs of the full and the compact models in the external validation were 0.842 (95% CI: 0.837–0.846) and 0.803 (95% CI: 0.798–0.809), respectively, which were still larger than those of Logistic Regression (0.660; 95% CI: 0.653–0.667) and SIC scores (0.752; 95% CI: 0.747–0.757). Prediction results were illustrated by SHapley Additive exPlanations (SHAP) values, which made our models clinically interpretable.Conclusions: We developed two models which were able to dynamically predict the risk of SIC in septic patients better than conventional Logistic Regression and SIC scores.

Highlights

  • Sepsis, defined as life-threatening organ dysfunction caused by a dysregulated host response to infection, remains the first leading cause of mortality in critically ill patients [1, 2]

  • Some drugs commonly administered in septic patients, such as linezolid and vancomycin, may alter coagulation function through various mechanisms and should be used with caution in patients with a high risk of coagulopathy [14]

  • These study results have heightened the need for early identification of coagulopathy in septic patients in a timely way

Read more

Summary

Introduction

Sepsis, defined as life-threatening organ dysfunction caused by a dysregulated host response to infection, remains the first leading cause of mortality in critically ill patients [1, 2]. The usefulness of anticoagulant therapies has not been confirmed in septic patients [7, 8]. Recent observational studies and subgroup analyses of large-scale randomized controlled trials revealed that anticoagulant therapies might result in a significant reduction in mortality risk and improved outcome in septic patients with coagulopathy [9,10,11,12]. Anticoagulant therapies in patients without coagulopathy should be avoided due to the increased risk of bleeding with no survival benefit [11, 13]. These study results have heightened the need for early identification of coagulopathy in septic patients in a timely way. Sepsis-induced coagulopathy (SIC) denotes an increased mortality rate and poorer prognosis in septic patients

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.